Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/Treatment

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

June 21, 2017

Study Completion Date

June 21, 2017

Conditions
CancerHematologic DisorderRheumatologic DisorderInfertility
Interventions
PROCEDURE

Ovarian Cryopreservation

The ovarian tissue will be removed at a UK Healthcare facility and evaluated for gross disease by a pathologist, embryologist, andrologist or REI physician. The ovarian cortex will be dissected from the medulla and cut into strips in culture/holding media, washed to remove blood cells, and cryopreserved. Cryopreservation will be performed using modifications of the techniques described by Gosden et al. (1994) or will be vitrified using a modification of the techniques of Kuwayama et al., 2007.

Trial Locations (2)

40202

Norton Health Care, Louisville

40536

University of Kentucky, Lexington

All Listed Sponsors
lead

Vlad Radulescu

OTHER

NCT02678910 - Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/Treatment | Biotech Hunter | Biotech Hunter